KT Intervention to Increase Use of Outcome Measures
Public ClinicalTrials.gov record NCT04052503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Knowledge Broker Facilitated Intervention to Increase Use of Outcome Measures by Physical Therapists
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Knowledge brokers can facilitate knowledge translation (KT) interventions to improve the use of outcome measures by physical therapists. Following the Knowledge-to-Action cycle, a knowledge broker (a researcher who facilitates the translation of knowledge in the local context) will: (1) complete a barrier assessment, (2) develop and implement a tailored multi-modal intervention and (3) determine the outcome. The KB will determine the barriers and facilitators to using outcome measures by PTs who work in inpatient rehabilitation and design a locally tailored KT intervention with input from the key stakeholders (PTs). This cluster randomized trial will compare two active interventions with full or partial supported implementation by a knowledge broker using a cluster randomized trial (randomization will occur by site) to determine the impact on the PTs and patients. Aim 1: Determine if the KT intervention designed and implemented by a KB will increase PTs the use of a selected standardized assessment as compared to an intervention that is designed but not implemented by the KB. Hypothesis1a: Physical therapists use (documented and self-reported) of a selected standardized assessment will improve to a significantly greater extent immediately following the intervention designed and implemented by a KB compared to the partially supported group. Hypothesis1b: Physical therapists in the fully supported group will retain the use of the standardized assessment to a significantly greater extent at 6 month follow-up. Aim 2: Explore and compare both groups of physical therapists satisfaction and concerns with each KT intervention on standardized assessment use. Hypothesis 2: The physical therapists in the fully supported group will express greater satisfaction with the KT intervention and identify fewer barriers for implementing the standardized assessment in practice as compared to the partially supported group immediately after and retained at 6 month follow-up. Aim 3: Explore and compare the patients' experience who were seen by therapists in the fully and partially supported group Hypothesis 3: Patients who were treated by clinicians in the fully supported group will demonstrate an understanding of the patient standardized assessment, why it's relevant to complete the test, and how the information gathered from the standardized assessment can be used to guide the plan of care.
Study identification
- NCT ID
- NCT04052503
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2016
- Primary completion
- Aug 3, 2017
- Completion
- Aug 3, 2017
- Last update posted
- Dec 16, 2020
2016 – 2017
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rutgers | Newark | New Jersey | 07107 | — |
| Kessler Institue for Rehabilitation | Saddle Brook | New Jersey | 07663 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04052503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2020 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04052503 live on ClinicalTrials.gov.